AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| NTL | Metallurgical Testwork Results - updated to include table | 04/04/18 | ||
| NTL | Final Director's Interest Notice - Mr McKee | 03/04/18 | ||
| NTL | Retirement of Director - James Murray McKee | 29/03/18 | ||
| NTL | Testwork reveals high recovery of gold | PRICE SENSITIVE | 22/03/18 | |
| NTL | Quarterly Activities Report | PRICE SENSITIVE | 31/01/18 | |
| NTL Metallurgical Testwork Results - updated to include table | |||
| 04/04/18 | |||
| NTL Final Director's Interest Notice - Mr McKee | |||
| 03/04/18 | |||
| NTL Retirement of Director - James Murray McKee | |||
| 29/03/18 | |||
| NTL Testwork reveals high recovery of gold | |||
| 22/03/18 | PRICE SENSITIVE | ||
| NTL Quarterly Activities Report | |||
| 31/01/18 | PRICE SENSITIVE | ||
